Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
3.788
-0.012 (-0.31%)
Nov 22, 2024, 4:00 PM EST - Market closed

Nanobiotix Revenue

Nanobiotix had revenue of 9.29M EUR in the half year ending June 30, 2024, with 598.95% growth. This brings the company's revenue in the last twelve months to 42.20M, up 526.17% year-over-year. In the year 2023, Nanobiotix had annual revenue of 36.21M with 658.12% growth.

Revenue (ttm)
42.20M EUR
Revenue Growth
+526.17%
P/S Ratio
n/a
Revenue / Employee
413,765 EUR
Employees
102
Market Cap
172.47M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202336.21M31.43M658.12%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M--
Mar 17, 2021---
Dec 31, 20202.33M-216.00K-8.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 444.20M
Heron Therapeutics 137.74M
Biodesix 65.56M
BrainsWay 38.63M
Senseonics Holdings 22.21M
MediWound 20.14M
Caribou Biosciences 11.48M
Revenue Rankings